Egypt Uveitis Therapeutics Market Analysis

Egypt Uveitis Therapeutics Market Analysis

$ 3999

Egypt Uveitis therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Uveitis is an inflammation of the uvea, which is the middle layer of the tissue that surrounds the eye and is made up of the iris, ciliary body, and choroid. The most typical extra-articular Spondyloarthritis symptom is uveitis (SpA) Increased healthcare financing, together with the development of drugs with improved efficacy and fewer side effects, has benefited technological advancements in the field, which together are serving as a potential driver of the uveitis therapeutic market. Several well-known companies involved in the development and marketing of uveitis medicines include Novartis AG, Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Johnson & Johnson, AbbVie Inc., and Allergan (now a division of AbbVie).

ID: IN10EGRD007 CATEGORY: Rare Diseases GEOGRAPHY: Egypt AUTHOR: Nipun Arora

Buy Now

Egypt Uveitis Therapeutics Market Analysis Summary

Egypt Uveitis Therapeutics Market is valued at around $4.48 Mn in 2022 and is projected to reach $7.04 Mn by 2030, exhibiting a CAGR of 5.8% during the forecast period 2023-2030.

Uveitis is an inflammation of the uvea, which includes the iris, ciliary body, and choroid as its middle layer of ocular tissue. The most typical extra-articular symptom of spondyloarthritis is uveitis (SpA) Anatomically speaking, uveitis can be anterior, middle, posterior, or widespread. Typically, uveitis is described as an inflammation of the iris and anterior chamber; intermediate uveitis is described as an inflammation of the ciliary body and vitreous humour (the jelly-like substance that fills the anterior portion of the eye); and posterior uveitis is described as an inflammation of the retina, choroid, or the optic disc (where the optic nerve enters the retina). Panuveitis, also known as diffuse uveitis, refers to inflammation throughout the whole uveal tract. Light sensitivity, red eyes, eye pain, or vision issues are some of the signs of uveitis. Eye drops containing corticosteroids are typically advised by doctors to treat uveitis and the ensuing inflammation. If the drops are ineffective, a physician can advise a tablet or an injection. Eye drops are first needed for uveitis. Injections, oral medicines, or immunosuppressive treatments are typically used to treat intermediate, posterior, or pan-uveitis. In some circumstances, a surgeon can also be required to remove the gel-like substance from the troubled eye. Technology advancements in the industry have contributed to the creation of medications with increased effectiveness and fewer side effects, combined with higher spending for healthcare, which together are serving as a potential driver of the uveitis therapeutics market. Allergan (now part of Novartis AG).

Market dynamics

Market Drivers

  • Focus on Personalized medicine

Personalized medicine techniques like genetic profiling and biomarker discovery are becoming more popular in the market for uveitis. These techniques help to enhance results, reduce side effects, and tailor treatment regimens for particular patients.

  • Technological developments

The accuracy of diagnoses and the efficacy of treatments are being improved through new diagnostic tools, imaging techniques, and therapeutic approaches.

  • Increasing healthcare spending

Increasing healthcare spending, especially in emerging economies, is enabling the creation and accessibility of cutting-edge Uveitis treatment options


Market Developments

In preclinical models, the efficacy and safety of BNSO-1 are clearly demonstrated. Before the end of 2023, BNSO plans to start a phase I/IIa clinical research with individuals who have chronic anterior uveitis. For this indication, BNS has secured FDA orphan status, and if the clinical trials are successful, BNS anticipates a faster 505b2 regulatory approval pathway.

Notable deals in Restraints in the Uveitis therapeutics market

A deal has been reached to form a new Ophthalmic company called BNS Ophthalmics between RAFARM, a Greek pharmaceutical company and recognised European manufacturer with expertise in ophthalmics, and BioNanoSim (BNS), an Israeli nanotechnology drug discovery and development company co-founded by Prof. Simon Benita and Yissum, the Transfer Technology and IP company of The Hebrew University of Jerusalem (BNSO). In order to meet the significant unmet ophthalmic needs of patients worldwide, BNSO will develop, produce, and market a variety of novel pharmaceutical solutions for the eyes.


Restraints in the Uveitis therapeutics market

  • The high cost of therapy 

The high expense of uveitis therapy is a key barrier for the industry. For instance, biologics can be very expensive, making it difficult for patients to access these medicines.

  • Medication side-effects

Immunosuppressants and corticosteroids are two examples of drugs used to treat anterior uveitis that may have long-term dangers and adverse effects. It is crucial to effectively track and manage these risks.

  • Lack of standardized treatment recommendations

Due to the lack of defined treatment recommendations, several therapy approaches are employed to treat uveitis. This could result in less than ideal management and make it challenging to compare the results of various treatments.

Key players

Novartis Pfizer Sanofi Roche AbbVie Amgen Celgene Gilead Sciences Johnson & Johnson Merck

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market segmentations for Egypt Uveitis therapeutics market

By Disease Type

  • Anterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
  • Posterior Uveitis

By Distribution Channel

  • Drug Stores and Retail Pharmacies
  • Hospital Pharmacies
  • Online
  • Others

By diagnosis

  • Laboratory tests such as blood tests
  • Imaging tests such as an MRI or CT scan

By treatment


  • Corticosteroid
  • Antimicrobial
  • Immunosuppressants



  • Phototherapy
  • Laser therapy 

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 July 2023
Updated by: Shivam Zalke

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter